R. McAnulty (London, United Kingdom), F. J. Martinez (Ann Arbor, United States of America)
IPF fibroblasts secrete low levels of KGF: involvement of the JNK pathway
S. Marchand-Adam, L. Plantier, D. Bernuau, M. Cohen, P. Soler, G. Leseche, H. Mal, M. Aubier, M. Dehoux, B. Crestani (Paris, Clichy, France)
|  |
TGFβ3 has differential effects of in the lung dependent on the underlying pathogenetic condition
M. Kolb, P. Bonniaud, K. Ask, G. Martin, J. Robertson, K. Meyer, J. Gauldie (Hamilton, Canada; Wuerzburg, Germany; Dijon, France)
|  |
Effect of PDGF receptor tyrosine kinase inhibitor AG1296 on bleomycin-induced lung fibrosis in mice
S. Fujimoto, Y. Ishii, T. Fukuda (Mibu, Japan)
| |
Enhanced lung fibrosis in protein C inhibitor transgenic mice
E. C. Gabazza, Y. Nishii, H. Nakahara, H. Fujimoto, H. Kobayashi, H. Yasui, C. N. D‘Alessandro-Gabazza, T. Hayashi, K. Suzuki, O. Taguchi (Tsu, Japan)
| |
Apoptosis in epithelial cells in patients with idiopathic pulmonary fibrosis
M. Plataki, A. V. Koutsopoulos, E. G. Tzortzaki, M. Zervou, G. Delides, N. M. Siafakas, D. Bouros (Heraklion, Alexandroupolis, Greece)
| |
Potential for proteinase-3 to contribute to pro-TNF-α cleavage in inflammatory lung disease
L. Armstrong, K. M. Uppington, A. B. Millar (Bristol, United Kingdom)
| |
The effects of chemokine-like factor1 on murine pulmonary fibrosis
Y. Tan, D. Ma, W. Han, Y. Chen, N. Zhong (Guangzhou, Beijing, China)
| |
Genetic polymorphism in matrix metalloproteinase-9 and the susceptibility to chronic obstructive pulmonary disease in Chinese population of Han nationality,China
Z. Min, H. Shaoguang, W. Huanying, D. Weiwu, L. I. Biao, L. I. Min (Shanghai, China)
| |